Fitz- Drugs that prevent DNA synthesis Flashcards

1
Q

What are the anti-metabolite cancer drugs?

A
5 FU
6 Mercaptopurine
6 Thiguanine
Allopurinol
cladarabine
cytarabine
fludarabine
gemcitabine
leucovorin
methotrexate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where does methotrexate act?

A

Methotrexate inhibits DHFR and prevents nucleotide synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where does 5FU act?

A

5 FU affects pyrimidine synthesis by inhibiting thymidylate synthase
ultimately leading to decreased dTMP and decreased DNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What drugs affect purine synthesis? How?

A

6-MP
6-TG

These drugs enter via the salvage pathway and must be activated by HGPRT. They are poor substrates for guanyl kinase and ultimately interfere w/ DNA/RNA synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What drug affects the conversion of ribonucleotides to deoxyribonucleotides?

A

Hydroxy urea inhibits ribonucleotide reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do the mechanisms of Methotrexate and premetrexed differ?

A

MTX- competitive inhibitor of DHFR

Premetrexed- antagonist of thymidalate synthase and purine synthase

Both lead to the inhibition of DNA synthesis, decreased methionine and AA synthesis/metab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What mechanisms make cancer cells more susceptible than normal sells to drugs (selective toxicity)?

A

Some cancer drugs over express the folate receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a leucovorin rescue?

A

Leucovorin is used w/ MTX to rescue host tissues from the effects of intense MTX therapy

Leucovorin provides normal tissues w. a way to bypass DHFR so you can use a higher dose of MTX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
How do the mechanisms of resistance differ between:
MTX
5-FU
6-MP
5-TG
A

MTX- change target enzyme (DHFR), decreases drug accum

5-FU-change target enzyme (TS), decreases activation of pro-drugs (pyrim mono kinase)

6-MP/5-TG-change target enz (PNP/HGPRT), decrease activation of pro-drug (HGPRT), increase inactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are 5-FU and capecitabine activated?

A

Capecitabine is converted to 5-FU. 5-FU then has to be activated by pyrimidine monophosphate kinase (UMP–UDP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is the activation of purine analogues unique?

A

6-MP and 6-TG have to be activated by HGPRT (combining PRPP w/ hypoxanthine/guanine bases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the unique SE of MTX?

A

Bone marrow suppression–> myelosupression

Aborficant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the unique SE of 5-FU?

A

LOOOW TI
myelosupression
Acute cerebellar syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the unique SE of 6-MP?

A

Bone marrow suppression

Tumor lysis syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference in the MOA of antimetabolite agents that block nucleotide synthesis vs those that act on DNA synthesizing enzymes?

A

Unlike agents that block nucleotide synthesis, inhibitors of DNA synthesizing enzymes DO NOT inhibit the nucleotide synthesis pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is tumor lysis syndrome?

A

The sudden rapid death of millions of cells—problem for pts w/ leukemia/lymphoma.

Results from development of electrolyte and metabolic disturbances (esp hyperuricemia) that produce life threatening complications

17
Q

How can you minimize the effects of tumor lysis syndrome?

A

Allopurinol–used during chemo of hematologic cancers to prevent hyperuricemia d/t tumor cell lysis

18
Q

Why are there concerns over administering allopurinol w/ 6-MP?

A

It can lead to excessive mercaptopurine toxicity (6-MP is also oxidized by xanthine oxidase) unless the dose of 6-MP is reduced.